689 results about "Full Term Neonate" patented technology

Embodiments of the present disclosure include an optical probe capable of communicating identification information to a patient monitor in addition to signals indicative of intensities of light after attenuation by body tissue. The identification information may indicate operating wavelengths of light sources, indicate a type of probe, such as, for example, that the probe is an adult probe, a pediatric probe, a neonatal probe, a disposable probe, a reusable probe, or the like. The information could also be utilized for security purposes, such as, for example, to ensure that the probe is configured properly for the oximeter, to indicate that the probe is from an authorized supplier, or the like. In one preferred embodiment, coding resistors could be provided across the light sources to allow additional information about the probe to be coded without added leads. However, any device could be used without it being used in parallel.

A flexible, conformable, sensor assembly is provided, including an electrode array especially adapted for stable, long-term recording of EEG signals from a pre-term or neonatal infant in intensive care. A kit or sterile pack includes guidance for placement of the electrodes over a designated area of the infant's brain, an area likely to be injured. The sensor assembly includes a left-side and a right-side flexible strip bearing at least electrodes and optional temperature, motion, and optical sensors provide for the monitoring of an extended range of parameters including aspects of cerebral perfusion and metabolism. Optional impedance measurements provide an indication of neuronal swelling. Stable performance over from three days to about a week is intended so that progress, effects of treatment, and outcome can be considered.

In a method for nasal ventilation and relevant apparatus, particularly for flow-synchronized neonatal assisted ventilation, wherein F(t) is a signal proportional to the ventilation flow, the following steps are performed:(a) inspiration, having a time length Ti, during which air is introduced at an inspiration pressure;(b) expiration, having a time length Te, during which the introduction of air is interrupted;(c) return to step (a);with a flow threshold Ftr, during the expiration step (b) the following steps are provided:(b1) a waiting step having a time length γ before activation of computation of the leakages; and(b2) a step of leakage computation, having a time length δ, so that γ+δ=Te, wherein if a normalized signal F′ (t), obtained by a processing by way of an algorithm of the surveyed signal F(t), exceeds the threshold Ftr, a spontaneous respiration activity is detected and the inspiration step (a) is reactivated.

A kit containing all the materials needed to take a blood sample from a neonatal patient, a pediatric patient, a juvenile patient or an adult patient. The materials are supplied in a plastic package suitable for sterilization.

The present invention premature neonate life support environmental cradle (SEC), adapted by means of shape and size to be accommodated within (i) an incubator for premature neonates; and (ii) a measurement device, especially an MRI device. The SEC is configured for a first at least one open position for accommodating said neonate whilst the SEC is within the incubator, and a second closed position for confinement of the neonate within a sealed volume of incubator atmosphere within the SEC such that the integrity of the confinement is maintained upon removal of the closed SEC containing the neonate from the incubator.

A transilluminator device for use with neonatal patients, which includes a power housing for providing power to the unit; a flexible cord, extending from the housing, and terminating in a small container for housing LED's; a plurality of red and white LED's containing the smaller housing, which are illuminated when power is provided to the LED's; the small housing positionable in the hands of a person, so that when a neonatal patient is placed in the person's hand the LED's will illuminate that portion of the neonatal person such as the arm, leg or other part of the anatomy in order to determine whether or not the physical conditions are normal or abnormal and to locate suitable veins for blood draws and IV therapy in an infant.

A docking-station useful for providing a neonate predefined, continuous, stabilized and non-interrupted life-support environmental conditions, comprising of: (i) a neonate incubator, having at least one first opening and a life support system, and (ii) an imaging-device, having a scanning chamber with at least one second opening. The docking-station is configured such that said neonate incubator first opening and said scanning chamber second opening are juxtapose-able so as to reversibly hermetically communicate; thereby providing said neonate predefined, continuous, stabilized, non-interrupted life-support environmental conditions during the entire process of scanning.

A magnetic resonance system (MRS), including a magnetic resonance device (MRD), comprising an open bore, the MRD at least partially contained in an envelope comprising in its circumference at least one recess; and, a cart made of MRI-safe material, comprising a base and at least one incubator above the base. The MRS is operative in a method of magnetic resonance imaging of neonates, comprising the steps of obtaining the MRS, the incubator is accommodated by a neonate; and inserting at least a portion of the cart into the MRD such that at least a portion of the incubator is inserted into the open bore and at least a portion of the base into at least one recess.

A thermal and moisture barrier device for use with a specialized heating and humidifying apparatus in the care of extremely premature neonatal infants. The thermal and moisture barrier comprises a collapsible and substantially flexible cover which defines an enclosed volume, large enough to accommodate an extremely premature neonatal infant. At least one flexible opening is located on a portion of the cover which communicates with the enclosed volume. A diaphragm provides closure of the flexible openings. The diaphragm is a resiliently flexible sheet extending across the opening and has slits.

A transfer station is provided that is suitable for use in association with an incubator and an MR scanner for neonatal infants. The transfer station may include a transfer station platform attached atop a transfer station base. The transfer station may be placed between and an incubator and an MR scanner and may include mechanisms for engaging the incubator and the MR scanner. The transfer station may include a movable bed for a patient that may be placed in the MR scanner.

The invention relates methods of reducing the risk or preventing the occurrence of an adverse event (AE) or a serious adverse event (SAE) associated with a medical treatment comprising inhalation of nitric oxide.

A sheath assembly for different fields of endoscopic surgery involving suction, irrigation and material removal which would on one hand enable reducing the size of keyhole to do the endoscopic surgery making it minimally invasive surgery, minimal damage to surrounding organ and practically no bleeding, faster recovery and early discharge and yet on the other hand provide for the advantages of big hole surgery. The sheath assembly of the invention would enable using variety of sheath sizes of different length and width of working sheath and thus facilitate applying to neonates as well as morbidly obese patients. The sheath assembly would enable endoscopic surgery such as percutaneous renal surgery with even about 3.0 mm inner diameter tubular sheath for large varieties of stones which would further add comfort and extra safety both for the patient as well as the surgeons.

An inhalation device, assembly or system can include a kit and a pharmaceutical composition. The device can be adapted for administering therapeutic aerosols to pediatric patients, including neonates, infants or toddlers. The device can further include a vibrating mesh aerosol generator that can be insertable into a flow channel of the inhalation device through a lateral opening, and a valved face mask. The device can be connectable to a gas source through which a gas, such as oxygen, can be received into the flow channel at a low flow rate.

Embodiments of the present disclosure include an optical probe capable of communicating identification information to a patient monitor in addition to signals indicative of intensities of light after attenuation by body tissue. The identification information may indicate operating wavelengths of light sources, indicate a type of probe, such as, for example, that the probe is an adult probe, a pediatric probe, a neonatal probe, a disposable probe, a reusable probe, or the like. The information could also be utilized for security purposes, such as, for example, to ensure that the probe is configured properly for the oximeter, to indicate that the probe is from an authorized supplier, or the like. In one preferred embodiment, coding resistors could be provided across the light sources to allow additional information about the probe to be coded without added leads. However, any device could be used without it being used in parallel.

The invention relates to methods for detecting microbial blood infections including sepsis in a subject, preferably a neonate or a non-neonate such as an adult, the method comprising real-time PCR reactions for detection of specific microorganisms. Said methods preferably include treatment of a subject following detection of a specific microorganism or group of microorganisms. The invention further relates to a kit of parts adapted for performing a method of the invention, a set of at least one forward or re verse primer or probe and a method for monitoring sepsis or for determining the efficacy of an anti-sepsis treatment.

This disclosure provides methods for quantifying individual amino acids in various bodily fluids obtained from a human patient. Also provided are reference ranges for normal amino acid levels in the various bodily fluids (e.g., blood plasma, urine, cerebrospinal fluid, and saliva) and for various age groups (e.g., neonates, infants, children, and adults).

The invention discloses an anesthesia machine system, comprising a gas source supply pipeline used for providing a gas source, a breathing circuit connected with a patient, and an air supply branch circuit, wherein a gas flow output end of the gas source supply pipeline and an air flow output end of the air supply branch circuit are respectively connected with the breathing circuit; the breathing circuit is internally provided with a pressure sensor used for measuring air pressure in the breathing circuit when the patient inhales; the air supply branch circuit comprises an air box, a one-way valve and a proportional electromagnetic valve which are sequentially connected by pipes along an air supply direction, wherein the opening degree of the proportional electromagnetic valve is changed according to measurement parameters measured by of the pressure sensor. The opening degree of the proportional electromagnetic valve is continuously changed and is also promoted to be changed by the change of a numerical value of the pressure sensor caused by neonatal tidal volume; anesthesia mixed gas is extruded by the pressure of airflow produced by the air box for the patient to use; the anesthesia machine system is accurate in control and wide in applicable people. The invention also discloses a control method of the anesthesia machine system.

The invention relates to an infant formula comprising a source of protein in an amount of not more than 2.0 g / 100 kcal, a source of lipids, a source of carbohydrate and a probiotic wherein the probiotic is present in an amount equivalent to between 102 and 105 cfu / g of dry formula. The invention further extends to the use of such an infant formula to modulate the immune system of a neonatal infant to promote the development in the first few weeks of the life of the infant of a beneficial intestinal microbiota comparable with that found in breast fed babies as well as to promote the maturation of the immune system of a neonatal infant in the first few weeks of life.

The invention discloses a multifunctional newborn nursing bed for gynaecology and obstetrics, and relates to the technical field of gynaecology and obstetrics. The bed comprises a support frame, a shaking table is arranged in the support frame, a steering mechanism driven by a driving motor and used for driving the shaking table to shake is arranged in a transmission case, a horizontally arrangedlifting plate is in transmission connection with the shaking table through a lifting mechanism, and a pair of L-shaped rods are in transmission connection with the bottom of the support frame throughan adjusting mechanism. The steering mechanism drives the rotating shaft to alternately rotate clockwise and anticlockwise, so that newborns in the shaking table can sleep peacefully in a shaking state; the steering mechanism is driven by the driving motor, the shaking table does not need to be shaken manually, so that the workload of medical staff is reduced; and the height of the lifting plate can be adjusted through the arranged lifting mechanism, so that physical examination can be conducted on the newborns in the shaking table conveniently, the newborns do not need to be held up frequently, the examination process is convenient and efficient, and the device can be moved conveniently through arranged walking wheels.

The present invention relates to a life cradle device for the purpose of inducing therapeutic hypothermia in neonates suffering from birth asphyxia. The device essentially consists of a rigid outer skeleton which could be fitted with removable mattresses containing form stable organic phase change materials effecting instant and sustained cooling. Multiple compartments of different phase change material composition functional at different temperatures are arranged in layers to replicate cooling performances as in conventional cascading systems. The device is also designed to have thermo-chromic indicators with an option of probes for automation control techniques. The device may also be fitted with thermostat controlled infant radiant warmer to automatically switch on when the infant is cooled down below requirement as a safety consideration.

The invention provides a RNA probe capable of simultaneously detecting multiple neonatal hereditary diseases and a qualitative detection method in vitro of multiple neonatal genetic metabolic diseases, and the detection method provided by the invention is used for reducing the detection cost. Specifically, the invention discloses a RNA probe capable of simultaneously detecting multiple neonatal hereditary diseases, and the design method of the RNA probe comprises the following steps: 1) obtaining exon regions of genes corresponding to the neonatal genetic metabolic diseases; 2) regulating an oligonucleotide design principle. 1760 oligonucleotide sequences of the RNA probe provided by the invention are specifically as shown in table 1. The invention further provides a kit containing the RNA probe, and the kit can be used for simultaneously detecting multiple neonatal hereditary diseases.

A novel system and method for fluid management for accurate continuous venovenous hemofiltration (CWH) in extracorporeal membrane oxygenation (ECMO). The fluid management or CWH system is automated and configured for operation as a stand alone unit and can be easily integrated with an ECMO system. The fluid management system is capable of producing either perfect or negative fluid balance between ultrafiltrate removal and replacement fluid delivery. The fluid management system can achieve electrolyte replacement over a range of flow rates needed to care for patients ranging from neonates to adults. Finally, the novel fluid management system preserves patient safety, maintains sterility during operation, is easy to operate, and is compact enough to fit near a patient's bed.

The invention discloses a neonatal jaundice blue light therapy incubator and a monitoring management system thereof. The neonatal jaundice blue light therapy incubator comprises a neonatal jaundice blue light therapy incubator body, a mobile terminal in communication connection with the neonatal jaundice blue light therapy incubator body, and a remote server in communication connection with the mobile terminal. The neonatal jaundice blue light therapy incubator solves the problem of individual-based jaundice treatment, so that the treatment process is more scientific and more effective, and the side effects generated from treatment are reduced. Remote control over the neonatal jaundice blue light therapy incubator is achieved, a medical worker can conveniently use the incubator, and the treatment risk is reduced. Standard management of jaundice treatment is achieved, a treatment scheme is completely recorded and uploaded to a far-end server, and contrastive analysis of the treatment effect and tracing are convenient. The effect that one management system manages multiple jaundice therapy incubators is achieved, and the work efficiency of medical workers is greatly improved.

Condensation or “rain-out” is a problem in breathing circuits and especially neonatal breathing circuits. The subject patent provides an improved breathing tube component for managing rain-out particularly in neonatal applications. In particular the breathing tube has a smooth inner bore, and an outer insulating layer containing stagnant gas and a heater wire.

A trunk houses an infant outfit and infant blanket appointed to clothe and swaddle a newborn infant on the momentous journey home from the hospital. Also included by the container are a plurality of cards adapted for documenting the joyous journey. The infant outfit, infant blanket, and cards are safely stored and displayed within the container. A memorabilia system and method are thereby provided for memorializing and commemorating the infant's first journey home from the hospital. The memorabilia system and method are operable to accommodate at least five generations of infant home journeys.

A toilet seat or receptacle, for use by newborns, infants, toddlers or preschoolers for assisting in their toilet training and toileting. The device includes a seat disposed about an opening, a head / backrest to which is attached a safety belt. It has one or more sound emitting devices to provide predetermined sounds used to induce or encourage the process of urination or defecation. It is configured for use with a toilet or potty or other toilet receptacle. The toilet seat has a left hand ramp portion configured to be disposed at a front left hand end of the toilet seat and configured for raising the left hand knee of the child towards the chest whilst sitting on the seat. The device also includes a right hand ramped configured to be disposed at a front right hand end of the toilet seat and configured for raising the right hand knee of the child towards the chest whilst sitting on the seat.

Automated seizure detection from within an electroencephalogram (EEG) by instrumental means employs novel algorithms within software, using specific measurements of individual waves in trains, rather than any “bulk” process. The acquired signal is filtered, the wave shapes are individually described within a number of parallel runs using a variety of parameters, then criteria (including regularity criteria) are calculated and applied in order to create raw detection results. Finally the raw results are “integrated” for display. As a result, reported seizures closely follow the incidence and duration of seizures detected by trained clinicians. The invention is useful in intensive-care monitoring of EEGs from neonates and in EEG monitoring in general.

The invention discloses a primer combination sequence and kit for detecting child safe medication-related gene mutation sites. The kit includes 23 pairs of amplification primers and 23 single-base extension primers; the 23 pairs of amplification primers can specifically amplify the 23 common mutation site regions of child safe medication-related genes, and the 23 single-base extension primers areused to detect the 23 mutation site genotypes of the child safe medication-related genes; and the kit further includes special reagents for pretreatment and detection. The kit provided by the invention can realize one-hole detection of the 23 mutations related to the clinical child safe medication-related genes, has high sensitivity, strong specificity and high accuracy, and is simple to operate,low in cost and high in throughput, the detection is fast, automatic interpretation of results is realized, and the clinical promotion and application are easy to realize; and the kit can be applied to the detection of the genes related to safe medication of newborns or children, guide clinical correct medication, avoid medication risks, reduce medication injury, and truly achieve precise medication.

The invention discloses a kit for screening and checking glucose-6-phosphate dehydrogenase (G6PD) deficiency of neonates and a preparation method for the kit. The kit for screening and checking the glucose-6-phosphate dehydrogenase (G6PD) deficiency of the neonates consists of substrate reagent dry powder, a substrate redissolved reagent, a copper reagent, a reaction board and filter paper dried blood spot quality control material. The detection result of the kit is high in accuracy and sensitivity, and the kit has the advantages of high stability, economy, simplicity, high efficiency and thelike; when the kit is applied to screening and checking for the neonates, the relevance ratio of heterozygote is improved; and the judgment accuracy is improved.